• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

线粒体分裂通过活性氧(ROS)在缺氧条件下导致卵巢癌细胞对顺铂产生耐药性。

Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cells.

机构信息

WCU Biomodulation, Department of Agricultural Biotechnology, Seoul National University, Seoul, 08826, Republic of Korea.

Cancer Research Institute, College of Medicine, Seoul National University, Seoul, 03080, Republic of Korea.

出版信息

Oncogene. 2019 Nov;38(45):7089-7105. doi: 10.1038/s41388-019-0949-5. Epub 2019 Aug 13.

DOI:10.1038/s41388-019-0949-5
PMID:31409904
Abstract

Mitochondria undergo fission and fusion continually for survival through the course of cellular adaption processes in response to changes in the surrounding environment. Dysregulated mitochondrial dynamics has been reported in various diseases including cancer. Under hypoxic conditions (<1% O), the relationship between mitochondrial dynamics and sensitivity to cisplatin (CDDP) was examined in ovarian cancer cells. We found that hypoxia promoted mitochondrial fission and CDDP resistance in ovarian cancer cells. Hypoxia-induced reactive oxygen species (ROS) caused an increase in mitochondrial fission, a response abolished by free radical scavenging with N-acetylcysteine (NAC) and Trolox. Also, treatment of hydrogen peroxide (HO) decreased inhibitory p-Drp1 (Ser637) content and increased mitochondrial fission. Suppression of mitochondrial fission enhanced the CDDP sensitivity of hypoxic ovarian cancer cells. Lastly, in tumor spheroids from malignant ascites or tissues of patients with advanced-stage ovarian cancer, pretreatment with Mdivi-1 increased the CDDP sensitivity. Taken together, our results implicate that hypoxia-induced ROS trigger mitochondrial fission and CDDP resistance through downregulation of p-Drp1 (Ser637) and Mfn1 in ovarian cancer cells. Inhibition of Drp1 by Mdivi-1 treatment or si-Drp1 transfection increased CDDP sensitivity of ovarian cancer cells under hypoxia. Therefore, mitochondrial dynamics of cancer cells adapting to the hypoxic tumor microenvironment could be a potential target for anticancer therapy.

摘要

线粒体在细胞适应过程中不断经历分裂和融合,以应对周围环境的变化而存活。在包括癌症在内的各种疾病中,已经报道了线粒体动力学的失调。在缺氧条件下(<1% O),研究了卵巢癌细胞中线粒体动力学与顺铂(CDDP)敏感性之间的关系。我们发现,缺氧促进了卵巢癌细胞中线粒体的分裂和 CDDP 的耐药性。缺氧诱导的活性氧(ROS)引起线粒体分裂增加,用 N-乙酰半胱氨酸(NAC)和 Trolox 进行自由基清除可消除这种反应。此外,过氧化氢(HO)的处理降低了抑制性 p-Drp1(Ser637)的含量并增加了线粒体的分裂。抑制线粒体分裂增强了缺氧卵巢癌细胞对 CDDP 的敏感性。最后,在恶性腹水的肿瘤球体或晚期卵巢癌患者的组织中,用 Mdivi-1 预处理增加了 CDDP 的敏感性。总之,我们的结果表明,缺氧诱导的 ROS 通过下调 p-Drp1(Ser637)和 Mfn1 触发了卵巢癌细胞中的线粒体分裂和 CDDP 耐药性。用 Mdivi-1 处理或 si-Drp1 转染抑制 Drp1 增加了缺氧条件下卵巢癌细胞对 CDDP 的敏感性。因此,适应缺氧肿瘤微环境的癌细胞的线粒体动力学可能成为抗癌治疗的潜在靶点。

相似文献

1
Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cells.线粒体分裂通过活性氧(ROS)在缺氧条件下导致卵巢癌细胞对顺铂产生耐药性。
Oncogene. 2019 Nov;38(45):7089-7105. doi: 10.1038/s41388-019-0949-5. Epub 2019 Aug 13.
2
Hypoxia-induced ROS promotes mitochondrial fission and cisplatin chemosensitivity via HIF-1α/Mff regulation in head and neck squamous cell carcinoma.缺氧诱导的 ROS 通过 HIF-1α/Mff 调控促进头颈部鳞状细胞癌中线粒体分裂和顺铂化疗敏感性。
Cell Oncol (Dordr). 2021 Oct;44(5):1167-1181. doi: 10.1007/s13402-021-00629-6. Epub 2021 Aug 30.
3
Piceatannol enhances cisplatin sensitivity in ovarian cancer via modulation of p53, X-linked inhibitor of apoptosis protein (XIAP), and mitochondrial fission.白皮杉醇通过调节 p53、X 连锁凋亡抑制蛋白(XIAP)和线粒体分裂增强卵巢癌细胞对顺铂的敏感性。
J Biol Chem. 2013 Aug 16;288(33):23740-50. doi: 10.1074/jbc.M113.487686. Epub 2013 Jul 5.
4
p53 is required for cisplatin-induced processing of the mitochondrial fusion protein L-Opa1 that is mediated by the mitochondrial metallopeptidase Oma1 in gynecologic cancers.在妇科癌症中,顺铂诱导的线粒体融合蛋白L-Opa1的加工过程需要p53参与,该过程由线粒体金属肽酶Oma1介导。
J Biol Chem. 2014 Sep 26;289(39):27134-27145. doi: 10.1074/jbc.M114.594812. Epub 2014 Aug 11.
5
MicroRNA-148a-3p enhances cisplatin cytotoxicity in gastric cancer through mitochondrial fission induction and cyto-protective autophagy suppression.微小RNA-148a-3p通过诱导线粒体分裂和抑制细胞保护性自噬增强顺铂对胃癌的细胞毒性。
Cancer Lett. 2017 Dec 1;410:212-227. doi: 10.1016/j.canlet.2017.09.035. Epub 2017 Sep 28.
6
Hypoxia-induced SENP3 promotes chemosensitivity and mitochondrial fission via deSUMOylation of Drp1.缺氧诱导的 SENP3 通过去 SUMOylation 促进 Drp1 促进化学敏感性和线粒体分裂。
Head Neck. 2024 Nov;46(11):2776-2788. doi: 10.1002/hed.27821. Epub 2024 May 21.
7
Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells.顺铂直接作用于线粒体诱导活性氧的产生,决定卵巢癌细胞的命运。
Cell Death Dis. 2019 Nov 7;10(11):851. doi: 10.1038/s41419-019-2081-4.
8
ABT737 induces mitochondrial pathway apoptosis and mitophagy by regulating DRP1-dependent mitochondrial fission in human ovarian cancer cells.ABT737 通过调控 DRP1 依赖性线粒体分裂诱导人卵巢癌细胞发生线粒体通路凋亡和线粒体自噬。
Biomed Pharmacother. 2017 Dec;96:22-29. doi: 10.1016/j.biopha.2017.09.111. Epub 2017 Nov 24.
9
Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway.Akt介导的卵巢癌顺铂耐药:p53对依赖半胱天冬酶的线粒体死亡途径作用的调节
Cancer Res. 2006 Mar 15;66(6):3126-36. doi: 10.1158/0008-5472.CAN-05-0425.
10
Prohibitin 1 interacts with p53 in the regulation of mitochondrial dynamics and chemoresistance in gynecologic cancers.抑素 1 通过与 p53 相互作用调节妇科癌症中线粒体动力学和化疗耐药性。
J Ovarian Res. 2022 Jun 7;15(1):70. doi: 10.1186/s13048-022-00999-x.

引用本文的文献

1
Mitophagy's impacts on cancer and neurodegenerative diseases: implications for future therapies.线粒体自噬对癌症和神经退行性疾病的影响:对未来治疗的启示
J Hematol Oncol. 2025 Aug 1;18(1):78. doi: 10.1186/s13045-025-01727-w.
2
Unlocking the mitochondrial functional code: unraveling the pathogenesis of ovarian cancer and innovative targets to inhibit malignant behavior.解开线粒体功能密码:揭示卵巢癌发病机制及抑制恶性行为的创新靶点。
J Transl Med. 2025 Jul 24;23(1):819. doi: 10.1186/s12967-025-06840-5.
3
Role of mitochondria in physiological activities, diseases, and therapy.

本文引用的文献

1
Tumor evolution and chemoresistance in ovarian cancer.卵巢癌中的肿瘤演变与化疗耐药性
NPJ Precis Oncol. 2018 Sep 17;2:20. doi: 10.1038/s41698-018-0063-0. eCollection 2018.
2
Evaluating Tumor Evolution via Genomic Profiling of Individual Tumor Spheroids in a Malignant Ascites.通过对恶性腹水单个肿瘤球体的基因组分析评估肿瘤演变。
Sci Rep. 2018 Aug 24;8(1):12724. doi: 10.1038/s41598-018-31097-y.
3
Increased mitochondrial fission is critical for hypoxia-induced pancreatic beta cell death.线粒体分裂增加对于缺氧诱导的胰腺β细胞死亡至关重要。
线粒体在生理活动、疾病及治疗中的作用。
Mol Biomed. 2025 Jun 19;6(1):42. doi: 10.1186/s43556-025-00284-5.
4
Pyruvate Kinase M1/2 Proteoformics for Accurate Insights into Energy Metabolism Abnormity to Promote the Overall Management of Ovarian Cancer Towards Predictive, Preventive, and Personalized Medicine Approaches.丙酮酸激酶M1/2蛋白质组学,用于准确洞察能量代谢异常,以促进卵巢癌的整体管理,迈向预测性、预防性和个性化医学方法。
Metabolites. 2025 Mar 16;15(3):203. doi: 10.3390/metabo15030203.
5
Mitochondria-associated non-coding RNAs and their impact on drug resistance.线粒体相关非编码RNA及其对耐药性的影响。
Front Pharmacol. 2025 Feb 26;16:1472804. doi: 10.3389/fphar.2025.1472804. eCollection 2025.
6
The Common Hallmarks and Interconnected Pathways of Aging, Circadian Rhythms, and Cancer: Implications for Therapeutic Strategies.衰老、昼夜节律和癌症的共同特征及相互关联途径:对治疗策略的启示
Research (Wash D C). 2025 Mar 5;8:0612. doi: 10.34133/research.0612. eCollection 2025.
7
Transplantation of gastric epithelial mitochondria into human gastric cancer cells inhibits tumor growth and enhances chemosensitivity by reducing cancer stemness and modulating gastric cancer metabolism.将胃上皮线粒体移植到人类胃癌细胞中可通过降低癌症干性和调节胃癌代谢来抑制肿瘤生长并增强化学敏感性。
Stem Cell Res Ther. 2025 Feb 23;16(1):87. doi: 10.1186/s13287-025-04223-7.
8
Rhein: An Updated Review Concerning Its Biological Activity, Pharmacokinetics, Structure Optimization, and Future Pharmaceutical Applications.大黄酸:关于其生物活性、药代动力学、结构优化及未来药物应用的最新综述
Pharmaceuticals (Basel). 2024 Dec 10;17(12):1665. doi: 10.3390/ph17121665.
9
Depleting chemoresponsive mitochondrial fission mediator DRP1 does not mitigate sarcoma resistance.消耗化学响应性线粒体分裂介质动力相关蛋白1(DRP1)并不能减轻肉瘤耐药性。
Life Sci Alliance. 2024 Dec 6;8(2). doi: 10.26508/lsa.202402870. Print 2025 Feb.
10
Targeting mitochondria: a novel approach for treating platinum-resistant ovarian cancer.靶向线粒体:治疗铂耐药性卵巢癌的新方法。
J Transl Med. 2024 Oct 25;22(1):968. doi: 10.1186/s12967-024-05770-y.
PLoS One. 2018 May 16;13(5):e0197266. doi: 10.1371/journal.pone.0197266. eCollection 2018.
4
TNF-α induces Drp1-mediated mitochondrial fragmentation during inflammatory cardiomyocyte injury.TNF-α 在炎性心肌细胞损伤中诱导 Drp1 介导的线粒体片段化。
Int J Mol Med. 2018 Apr;41(4):2317-2327. doi: 10.3892/ijmm.2018.3385. Epub 2018 Jan 15.
5
FIH Is an Oxygen Sensor in Ovarian Cancer for G9a/GLP-Driven Epigenetic Regulation of Metastasis-Related Genes.FIH 是卵巢癌中的一种氧传感器,通过 G9a/GLP 驱动的表观遗传调控转移相关基因。
Cancer Res. 2018 Mar 1;78(5):1184-1199. doi: 10.1158/0008-5472.CAN-17-2506. Epub 2017 Dec 19.
6
The potential therapeutic effect of melatonin on human ovarian cancer by inhibition of invasion and migration of cancer stem cells.褪黑素通过抑制肿瘤干细胞的侵袭和迁移对人卵巢癌的潜在治疗作用。
Sci Rep. 2017 Dec 6;7(1):17062. doi: 10.1038/s41598-017-16940-y.
7
Screening drug effects in patient-derived cancer cells links organoid responses to genome alterations.在患者来源的癌细胞中筛选药物作用将类器官的反应与基因组改变联系起来。
Mol Syst Biol. 2017 Nov 27;13(11):955. doi: 10.15252/msb.20177697.
8
Pro-inflammatory M1 macrophage enhances metastatic potential of ovarian cancer cells through NF-κB activation.促炎型 M1 巨噬细胞通过 NF-κB 激活增强卵巢癌细胞的转移能力。
Mol Carcinog. 2018 Feb;57(2):235-242. doi: 10.1002/mc.22750. Epub 2017 Nov 14.
9
PGC1α induced by reactive oxygen species contributes to chemoresistance of ovarian cancer cells.活性氧诱导的PGC1α促进卵巢癌细胞的化疗耐药性。
Oncotarget. 2017 Jul 10;8(36):60299-60311. doi: 10.18632/oncotarget.19140. eCollection 2017 Sep 1.
10
Ovarian cancer recurrence and early detection: may HE4 play a key role in this open challenge? A systematic review of literature.卵巢癌复发与早期检测:HE4 在这一开放性挑战中可能发挥关键作用?文献系统综述。
Med Oncol. 2017 Aug 20;34(9):164. doi: 10.1007/s12032-017-1026-y.